Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,71 USD | +1,79% | -10,00% | -24,00% |
21/03 | VOR BIOPHARMA INC. : Stifel Nicolaus herhaalt koopadvies voor het aandeel | ZM |
21/03 | VOR BIOPHARMA INC. : Oppenheimer geeft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | 1,43 mln. 1,34 mln. | Marktkapitalisatie | 115 mln. 108 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -102 mln. -95,75 mln. | Nettowinst (verlies) 2025 * | -115 mln. -108 mln. | EV/omzet 2024 * | - |
Nettoschuld 2024 * | 16,29 mln. 15,29 mln. | Nettoliquiditeiten 2025 * | 52,11 mln. 48,92 mln. | EV/omzet 2025 * | 43,7 x |
K/w-verhouding 2024 * |
-1,21
x | K/w-verhouding 2025 * |
-1,24
x | Werknemers | 168 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,73% |
1 dag | +1,79% | ||
1 week | -10,00% | ||
Lopende maand | -27,85% | ||
1 maand | -6,04% | ||
3 maanden | -24,50% | ||
6 maanden | -22,27% | ||
Lopend jaar | -24,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 07-08-19 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 01-05-20 |
Chief Tech/Sci/R&D Officer | 51 | 01-10-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 30-07-20 |
Matt Patterson
CHM | Chairman | 52 | 20-10-20 |
Bob Ang
CEO | Chief Executive Officer | 49 | 07-08-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +1,25% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 1,71 | +1,79% | 199 054 |
18-04-24 | 1,68 | -2,89% | 153 149 |
17-04-24 | 1,73 | +1,17% | 169 880 |
16-04-24 | 1,71 | -5,00% | 350 333 |
15-04-24 | 1,8 | -5,26% | 304 227 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,00% | 115 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |